Researchers identified a protein-based defense pathway that helps neurons resist ferroptosis and oxidative stress after traumatic spinal cord injury. Strengthening this pathway improved motor recovery in injured mice by preserving sirtuin 6 (SIRT6) and activating nuclear factor erythroid 2-related factor 2 (NRF2).
Researchers found that 4-phenylbutyric acid (4-PBA) restored mitochondrial balance and reduced inflammation in the septic heart. The compound lowered lactate production, limited actin-related protein 2/3 complex subunit 1B modification, and preserved cardiac contraction.
Researchers developed stronger stem cell-derived extracellular vesicles to rebuild damaged microvessels and heal diabetic wounds more effectively. The treatment improved tissue remodeling, restored angiogenesis, and reduced oxidative stress in mouse and miniature pig models.
Researchers identified a distinct fibrotic fibroblast population in hypertrophic scars, which they linked to the transcription factor Yin Yang 1 (YY1). Restoring YY1 expression reduced scar-associated fibroblast activation, providing new insights into scar fibrosis and potential therapeutic strategies.
Researchers found that metformin reduced neuroinflammation, suppressed neuronal pyroptosis, and improved mitochondrial function after traumatic brain injury. The study highlights Mfn1 as a crucial molecular link between mitochondrial homeostasis and NLRP3 inflammasome.
A new imaging strategy combines dissolvable microneedles with a methylene blue-based nanoparticle tracer to produce clearer images of lymphatic vessels and nodes. The system also reveals segmental contractions linked to lymphatic pumping, opening a path toward more refined visualization and functional assessment.
The NLRP3 inflammasome plays a dynamic role in regulating acute wound healing by synchronizing macrophage behavior and promoting tissue restoration. Temporally modulating NLRP3 activity improved tissue regeneration, reduced scarring, and enhanced healing quality.
Researchers found that disabling TRIM13 enhances survival in a mouse model of polymicrobial sepsis. The study suggests targeting TRIM13 or its associated ER quality control machinery as a potential strategy for reprogramming immune competence.
Researchers develop a hybrid nanovesicle platform that addresses oxidative stress, inflammation, and impaired blood vessel growth in diabetic wounds. The treatment improves wound closure, vascular regeneration, and immune balance in diabetic mouse models.
Researchers discover that butyric acid, a gut microbiota-derived metabolite, enhances the activity of natural killer cells expressing CX3CR1, restoring immune cell migration and cytokine production. This gut-lung immune axis may be harnessed to improve outcomes in severe bacterial infections.
A randomized clinical study found that adding a fungal probiotic to standard enteral nutrition reduced nosocomial infections in critically ill patients with severe pancreatitis. The intervention also stabilized intestinal and respiratory microbiota, highlighting the potential of microbiome-targeted therapies. Fungal probiotics may offe...
A new bioactive wound dressing combining miR-221-3p and GelMA hydrogel promotes blood vessel formation, accelerating diabetic wound healing. The study shows a 90% wound closure rate within 12 days in animal trials.
A novel hydrogel has been developed to accelerate wound healing in infected wounds by regulating the skin microbiota. The hydrogel, PSG15, inhibited bacterial growth and promoted tissue regeneration, enhancing angiogenesis and collagen deposition.
Researchers developed an electrospun scaffold loaded with copper oxide to restore copper homeostasis and modulate inflammation in TBI. The study found significant reductions in neuronal pyroptosis, brain swelling, and improved motor and cognitive functions in animal models.
Researchers investigate the role of NUFIP1 in modulating dendritic cell activation during sepsis. They found that NUFIP1 facilitates dendritic cell function by mitigating excessive ER stress, leading to improved immune responses and survival outcomes in septic models.
Researchers have identified a novel therapeutic pathway for treating keloid scars by targeting the enzyme CYP24A1 and vitamin D. The study found that inhibiting CYP24A1 can reduce profibrotic gene expression, offering a fresh perspective on keloid treatment strategies.
Researchers developed a pioneering skin organoid model using air-liquid interface culture, significantly enhancing hair follicle growth and maturation. The study offers refined models for studying skin diseases and crafting innovative therapeutic solutions.
Researchers have identified vitamin D and CYP24A1 as key factors in keloid scar development, providing a novel therapeutic pathway to mitigate fibrotic characteristics. Inhibiting CYP24A1 may improve treatment efficacy and prevent recurrence.